Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03168113 · ClinicalTrials.gov registry record

Atopic Dermatitis (AD) and Food Allergy

A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
62
Enrollment target

NCT03168113 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 62 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03168113 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
62 participants
Enrollment target

Study Summary

This is a prospective, single center, clinical mechanistic pilot clinical research study. Participants will not receive any investigational agent. The investigators will examine whether children with atopic dermatitis (AD) and food allergy have a different skin barrier, microbiome, epidermal transcriptome, and epidermal lipid composition than children with AD and no food allergy and non-atopic (NA) children. Participation involves a single study visit.

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2017-06-12
Est. Completion 2018-01-31

What the Registry Record Tells You About NCT03168113

The ClinicalTrials.gov registry entry for NCT03168113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03168113 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03168113 about?

NCT03168113 is a clinical study titled "Atopic Dermatitis (AD) and Food Allergy". This is a prospective, single center, clinical mechanistic pilot clinical research study. Participants will not receive any investigational agent. The investigators will examine whether children with atopic dermatitis (AD) and food allergy have a different skin barrier, microbiome, epidermal transcr...

What is the current status of trial NCT03168113?

This trial is currently completed. The enrollment target is 62 participants. The study started on 2017-06-12. Estimated completion is 2018-01-31.

Who is sponsoring clinical trial NCT03168113?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.